Please login to the form below
5
Revenue 2017Avastin
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avastin was produced by Roche.
EU approval for Opdivo combo in renal cell cancer
category with its IMmotion 151 study comparing PD-L1 inhibitor Tecentriq plus Avastin to Sutent, which showed positive effects on PFS at last year’s ASCO meeting.
Chi-Med and Lilly’s cancer drug Elunate a milestone for China
The VEGF-inhibitor class is already well-established outside China – in fact Roche’s Avastin is now available as a biosimilar in Europe – but it has never been approved in China,
Roche pulls EU Tecentriq/Avastin filing in kidney cancer
combination of Tecentriq and Avastin may play a role in the treatment of metastatic RCC [which] remains an area of high unmet medical need.”. ... In that trial Tecentriq and Avastin were compared to chemotherapy in non-squamous NSCLC.
Roche’s new flu pill Xofluza approved in US
Roche is in need of a new set of innovative products, as its older generation of blockbusters, Avastin, Herceptin and MabThera/Rituxan come under competition from biosimilars.
Keytruda hits survival targets in first-line kidney cancer
with its IMmotion 151 study comparing PD-L1 inhibitor Tecentriq (atezolizumab) plus Avastin (bevacizumab) to Sutent, which showed positive effects on PFS at this year’s ASCO meeting.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
-
Senior Account Manager
-
Competitive Salary Offered
- Global Business Development Director – Health Education
-
excellent commission
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Account Director, Medical Education
-
Salary TBC
-
Account Manager / Account Director
-
Competative
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Medical Writer
-
Salary TBC
-
Business Director
-
Competitive Salary Offered
-
Account Director
-
Competitive Salary Offered
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
Subscribe to our email news alerts
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
- NICE gives Lilly’s Verzenios chance to compete with rivals
- J&J’s Erleada cleared for early prostate cancer in Europe
- New faces at Lucid, 90Ten and Page & Page
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
